Pharma Delegates Book in PDF, ePub and Kindle version is available to download in english. Read online anytime anywhere directly from your device. Click on the download button below to get a free pdf file of Pharma Delegates book. This book definitely worth reading, it is an incredibly well-written.
This book provides a broad overview of Japans health-care industry as a context for its true purpose. That purpose is to describe the historical development over a half century from the 1960s of an international voluntary organization of pharmaceutical and service-company executives comprising both foreign and Japanese members. Known as Pharma Delegates, they gather regularly for forums and fellowship on an informal basis, while also attracting high-level speakers to their monthly luncheons and annual seminars. The book is not about the pharmaceutical industry itself. Rather, it is about the people who make the industry successful through mutual self-help, where even competitors smile at each other.
This book provides a broad overview of Japan's health-care industry as a context for its true purpose. That purpose is to describe the historical development over a half century from the 1960s of an international voluntary organization of pharmaceutical and service-company executives comprising both foreign and Japanese members. Known as Pharma Delegates, they gather regularly for forums and fellowship on an informal basis, while also attracting high-level speakers to their monthly luncheons and annual seminars. The book is not about the pharmaceutical industry itself. Rather, it is about the people who make the industry successful through mutual self-help, where even competitors smile at each other.
It's Worth Doing is a must read for anyone engaged in cross-border dealings with Japan in the pharmaceutical industry. This book offers a wealth of insight that you will find invaluable whether you are a veteran Japan hand or new to the nation, whether you are a senior executive or a newly hired medical representative. P. Reed Maurer shares his decades of experience and expertise through brilliantly penned colums that are always interesting, frequently funny, and sometimes--as in the title piece--gripping. In succinct and thoroughly enjoyable prose, Maurer imparts the esence of what you will need to know to succeed in Japan. The columns collected in this volume provide a sweeping historical perspective on Japan's pharmaceutical industry and an inside view of how companies in that industry compete. They furnish practical hints about how to manage and motivate people effectively at pharmaceutical operations in Japan and how to build a strong corporate image there. Maurer exposes myths and misunderstandings about doing business in Japan, refuting them with an objective clarity that is a joy to read. It's Worth Doing is even more, however, than a treasure trove of information and insight. True to its title, the book is a compelling reminder of why you are in the pharmaceutical business. Rob Schrull President Global Business Leaders Association
Author : American Medical Association Publisher : Unknown Page : 950 pages File Size : 55,7 Mb Release : 1890 Category : American Medical Association ISBN : UOM:39015070312973
National Institutes of Health (U.S.). Division of Resources Analysis
Author : National Institutes of Health (U.S.). Division of Resources Analysis Publisher : Unknown Page : 130 pages File Size : 52,6 Mb Release : 1923 Category : Federal aid to higher education ISBN : OSU:32435025548355
DHEW Obligations to Institutions of Higher Education and Other Nonprofit Organizations by National Institutes of Health (U.S.). Division of Resources Analysis Pdf
How the hidden trade in our sensitive medical information became a multibillion-dollar business, but has done little to improve our health-care outcomes Hidden to consumers, patient medical data has become a multibillion-dollar worldwide trade industry between our health-care providers, drug companies, and a complex web of middlemen. This great medical-data bazaar sells copies of the prescription you recently filled, your hospital records, insurance claims, blood-test results, and more, stripped of your name but possibly with identifiers such as year of birth, gender, and doctor. As computing grows ever more sophisticated, patient dossiers become increasingly vulnerable to reidentification and the possibility of being targeted by identity thieves or hackers. Paradoxically, comprehensive electronic files for patient treatment—the reason medical data exists in the first place—remain an elusive goal. Even today, patients or their doctors rarely have easy access to comprehensive records that could improve care. In the evolution of medical data, the instinct for profit has outstripped patient needs. This book tells the human, behind-the-scenes story of how such a system evolved internationally. It begins with New York advertising man Ludwig Wolfgang Frohlich, who founded IMS Health, the world’s dominant health-data miner, in the 1950s. IMS Health now gathers patient medical data from more than 45 billion transactions annually from 780,000 data feeds in more than 100 countries. Our Bodies, Our Data uncovers some of Frohlich’s hidden past and follows the story of what happened in the following decades. This is both a story about medicine and medical practice, and about big business and maximizing profits, and the places these meet, places most patients would like to believe are off-limits. Our Bodies, Our Data seeks to spark debate on how we can best balance the promise big data offers to advance medicine and improve lives while preserving the rights and interests of every patient. We, the public, deserve a say in this discussion. After all, it’s our data.
